Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gut microbiome-related effects of berberine and probiotics on type 2 diabetes (the PREMOTE study)
Yifei Zhang, Yanyun Gu, Huahui Ren, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 273

Showing 1-25 of 273 citing articles:

Aging and aging-related diseases: from molecular mechanisms to interventions and treatments
Jun Guo, Xiuqing Huang, Lin Dou, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 745
New opportunities and challenges of natural products research: When target identification meets single-cell multiomics
Yuyu Zhu, Zijun Ouyang, Haojie Du, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 11, pp. 4011-4039
Open Access | Times Cited: 253
Probiotics impact the antibiotic resistance gene reservoir along the human GI tract in a person-specific and antibiotic-dependent manner
Emmanuel Montassier, Rafael Valdés‐Mas, Éric Batard, et al.
Nature Microbiology (2021) Vol. 6, Iss. 8, pp. 1043-1054
Open Access | Times Cited: 162
Probiotics, prebiotics, and postbiotics in health and disease
Jing Ji, Weilin Jin, Shuang‐Jiang Liu, et al.
MedComm (2023) Vol. 4, Iss. 6
Open Access | Times Cited: 150
Gut Microbiota and Type 2 Diabetes Mellitus: Association, Mechanism, and Translational Applications
Lili Zhang, Jinjin Chu, Wenhao Hao, et al.
Mediators of Inflammation (2021) Vol. 2021, pp. 1-12
Open Access | Times Cited: 111
Diet-gut microbiota-epigenetics in metabolic diseases: From mechanisms to therapeutics
Dan Li, Yujuan Li, Shengjie Yang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113290-113290
Open Access | Times Cited: 101
Resistant starch intake facilitates weight loss in humans by reshaping the gut microbiota
Huating Li, Lei Zhang, Jun Li, et al.
Nature Metabolism (2024) Vol. 6, Iss. 3, pp. 578-597
Open Access | Times Cited: 71
Interactions between gut microbiota and polyphenols: A mechanistic and metabolomic review
Hao Cheng, Dandan Zhang, Jing Wu, et al.
Phytomedicine (2023) Vol. 119, pp. 154979-154979
Closed Access | Times Cited: 70
Targeting the gut microbiota and its metabolites for type 2 diabetes mellitus
Jiaqiang Wu, Kangping Yang, Hancheng Fan, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 68
Less is more: Antibiotics at the beginning of life
Martin Stocker, Claus Klingenberg, Lars Navér, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 61
Glycoursodeoxycholic acid regulates bile acids level and alters gut microbiota and glycolipid metabolism to attenuate diabetes
Bingting Chen, Yu Bai, Fenglian Tong, et al.
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 60
Advances in Research on Type 2 Diabetes Mellitus Targets and Therapeutic Agents
Jingqian Su, Yingsheng Luo, Shan Hu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13381-13381
Open Access | Times Cited: 46
Perspectives on Berberine and the Regulation of Gut Microbiota: As an Anti-Inflammatory Agent
Quintero Vargas Jael Teresa de Jesús, J.C. Galvez-Ruiz, Adriana Alejandra Márquez Ibarra, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 193-193
Open Access | Times Cited: 2
Gut–X axis
Lin Xu, Yu Zhang, Xueyan Li, et al.
iMeta (2025) Vol. 4, Iss. 1
Open Access | Times Cited: 2
Disentangling Organ‐Specific Roles of Farnesoid X Receptor in Bile Acid and Glucolipid Metabolism
Tingting Li, Chenyang Fu, Zhongzheng Tang, et al.
Liver International (2025) Vol. 45, Iss. 4
Open Access | Times Cited: 2
New insight into intestinal toxicity accelerated by aged microplastics with triclosan: inflammation regulation by gut microbiota-bile acid axis
Dawu Lin, Xiangyu Chen, Xiaojun Lin, et al.
Journal of Hazardous Materials (2025) Vol. 492, pp. 138308-138308
Closed Access | Times Cited: 2
Modulating the Microbiota as a Therapeutic Intervention for Type 2 Diabetes
M. Nazmul Huda, Myungsuk Kim, Brian J. Bennett
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 95
An insight into the medicinal attributes of berberine derivatives: A review
Sobhi Gaba, Anjali Saini, Gurpreet Singh, et al.
Bioorganic & Medicinal Chemistry (2021) Vol. 38, pp. 116143-116143
Closed Access | Times Cited: 93
Combined berberine and probiotic treatment as an effective regimen for improving postprandial hyperlipidemia in type 2 diabetes patients: a double blinded placebo controlled randomized study
Shujie Wang, Huahui Ren, Huanzi Zhong, et al.
Gut Microbes (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 75
The role of the gut microbiota in health and cardiovascular diseases
Lu Wang, Shiqi Wang, Qing Zhang, et al.
Molecular Biomedicine (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 70
The Effects of Delivery Mode on the Gut Microbiota and Health: State of Art
Chenchen Zhang, Lixiang Li, Bi-ying Jin, et al.
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 69
Mitophagy and mitochondrial dynamics in type 2 diabetes mellitus treatment
Shan Zhao, Wei Hong Fa, Chen Run Tian, et al.
Aging (2022) Vol. 14, Iss. 6, pp. 2902-2919
Open Access | Times Cited: 68
Gut microbiota specifically mediates the anti-hypercholesterolemic effect of berberine (BBR) and facilitates to predict BBR’s cholesterol-decreasing efficacy in patients
Chongming Wu, Ying Zhao, Yingying Zhang, et al.
Journal of Advanced Research (2021) Vol. 37, pp. 197-208
Open Access | Times Cited: 60
Berberine, a Herbal Metabolite in the Metabolic Syndrome: The Risk Factors, Course, and Consequences of the Disease
Anna Och, Marek Och, Renata Nowak, et al.
Molecules (2022) Vol. 27, Iss. 4, pp. 1351-1351
Open Access | Times Cited: 52
Apoptosis Induction, a Sharp Edge of Berberine to Exert Anti-Cancer Effects, Focus on Breast, Lung, and Liver Cancer
Yi Zhun Zhu, Na Xie, Yilu Chai, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 48
Page 1 - Next Page

Scroll to top